Japan's Catalys Pacific targets $100m for first VC healthcare fund

Japan's Catalys Pacific targets $100m for first VC healthcare fund

An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California, U.S., on Wednesday, Feb. 8, 2012. Photographer: David Paul Morris/Bloomberg

Catalys Pacific, a new venture capital firm from Japan, has launched its first $100-million healthcare fund.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter